More strikingly, recent clinical and preclinical studies revealed that Lp‐PLA2 inhibition showed promising therapeutic effects in diabetic macular edema and Alzheimer's disease. Here, PLA2G7 is linked to early-onset autosomal dominant Alzheimer disease.